Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 1:2:976039.
doi: 10.3389/fepid.2022.976039. eCollection 2022.

Treatment gaps in epilepsy

Affiliations
Review

Treatment gaps in epilepsy

Jacob Pellinen. Front Epidemiol. .

Abstract

Over 50 million people around the world have epilepsy, and yet, epilepsy recognition and access to care are ongoing issues. Nearly 80% of people with epilepsy live in low-and middle-income countries and face the greatest barriers to quality care. However, there are substantial disparities in care within different communities in high-income countries as well. Across the world, under-recognition of seizures continues to be an issue, leading to diagnostic and treatment delays. This stems from issues surrounding stigma, public education, basic access to care, as well as healthcare worker education. In different regions, people may face language barriers, economic barriers, and technological barriers to timely diagnosis and treatment. Even once diagnosed, people with epilepsy often face gaps in optimal seizure control with the use of antiseizure medications. Additionally, nearly one-third of people with epilepsy may be candidates for epilepsy surgery, and many either do not have access to surgical centers or are not referred for surgical evaluation. Even those who do often experience delays in care. The purpose of this review is to highlight barriers to care for people with epilepsy, including issues surrounding seizure recognition, diagnosis of epilepsy, and the initiation and optimization of treatment.

Keywords: accessibility; barriers; diagnoisis; disparities; healthcare delivery; neurology; underutilization.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Conceptual framework for the timeline of diagnostic delay in epilepsy and specific barriers at each stage.

Similar articles

Cited by

References

    1. Zelano J, Klecki J, Christensen J, Tomson T, Malmgren K, Kruja J, et al. . The provision of epilepsy care across Europe 2017: A 17-year follow-up survey. Epilepsia open. (2019) 4:144–52. 10.1002/epi4.12306 - DOI - PMC - PubMed
    1. Kwon CS, Wagner RG, Carpio A, Jetté N, Newton CR, Thurman DJ. The worldwide epilepsy treatment gap: a systematic review and recommendations for revised definitions – a report from the ILAE Epidemiology Commission. Epilepsia. (2022) 63:551–64. 10.1111/epi.17112 - DOI - PubMed
    1. Spiciarich MC, von Gaudecker JR, Jurasek L, Clarke DF, Burneo J, Vidaurre J. Global health and epilepsy: update and future directions. Curr Neurol Neurosci Rep. (2019) 19:30. 10.1007/s11910-019-0947-6 - DOI - PubMed
    1. Pellinen J, Erica T, Yang A, Price D, Friedman D, Holmes M, et al. . Focal non-motor vs motor seizures: the impact on diagnostic delay in focal epilepsy. Epilepsia. (2020) 61:2643–52. 10.1111/epi.16707 - DOI - PubMed
    1. Firkin AL, Marco DJT, Saya S, Newton MR, O'Brien TJ, Berkovic SF, et al. . Mind the gap: Multiple events and lengthy delays before presentation with a ‘first seizure'. Epilepsia. (2015) 56:1534–41. 10.1111/epi.13127 - DOI - PubMed

LinkOut - more resources